Cargando…
Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
BACKGROUND: Infection of B-cells with Epstein–Barr virus (EBV) leads to more and subsequent immortalization. This is considered as the method of choice for generating lymphoblastoid cell lines (LCLs). Producing LCLs, although very useful but is very time consuming and troublesome, drives the require...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539668/ https://www.ncbi.nlm.nih.gov/pubmed/28808646 http://dx.doi.org/10.4103/2277-9175.210659 |
_version_ | 1783254524354363392 |
---|---|
author | Tousizadeh, Behnaz Moghim, Sharareh Chaleshtori, Ahmad Reza Salehi Ghanbarian, Maryam Mirian, Mina Salehi, Mansoor Tousizadeh, Sepideh Zaboli, Fatemeh |
author_facet | Tousizadeh, Behnaz Moghim, Sharareh Chaleshtori, Ahmad Reza Salehi Ghanbarian, Maryam Mirian, Mina Salehi, Mansoor Tousizadeh, Sepideh Zaboli, Fatemeh |
author_sort | Tousizadeh, Behnaz |
collection | PubMed |
description | BACKGROUND: Infection of B-cells with Epstein–Barr virus (EBV) leads to more and subsequent immortalization. This is considered as the method of choice for generating lymphoblastoid cell lines (LCLs). Producing LCLs, although very useful but is very time consuming and troublesome, drives the requirement for quicker and more reliable methods for EBV-driven B-cell transformation. MATERIALS AND METHODS: After successfully production of LCLs, different parameters including temperature, serum concentration, type of culture medium, and CO(2) concentration were evaluated on EBV-transformed B-cells. In this study, we were able to produce LCLs and optimize condition. RESULTS: The best condition for generating LCLs was 37°C, 5% CO(2), 20% fasting blood sugar, and RPMI 1640. The study results were to establish a reliable method for producing LCLs that can be used to produce immortalized B-cells from almost any sources. CONCLUSION: This can help with tumorgenecity studies, as well as producing control material for rare genetic disorders and so on. The aim of this study was to determine optimized condition for reliable and reproducible LCLs from different sources. |
format | Online Article Text |
id | pubmed-5539668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55396682017-08-14 Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies Tousizadeh, Behnaz Moghim, Sharareh Chaleshtori, Ahmad Reza Salehi Ghanbarian, Maryam Mirian, Mina Salehi, Mansoor Tousizadeh, Sepideh Zaboli, Fatemeh Adv Biomed Res Original Article BACKGROUND: Infection of B-cells with Epstein–Barr virus (EBV) leads to more and subsequent immortalization. This is considered as the method of choice for generating lymphoblastoid cell lines (LCLs). Producing LCLs, although very useful but is very time consuming and troublesome, drives the requirement for quicker and more reliable methods for EBV-driven B-cell transformation. MATERIALS AND METHODS: After successfully production of LCLs, different parameters including temperature, serum concentration, type of culture medium, and CO(2) concentration were evaluated on EBV-transformed B-cells. In this study, we were able to produce LCLs and optimize condition. RESULTS: The best condition for generating LCLs was 37°C, 5% CO(2), 20% fasting blood sugar, and RPMI 1640. The study results were to establish a reliable method for producing LCLs that can be used to produce immortalized B-cells from almost any sources. CONCLUSION: This can help with tumorgenecity studies, as well as producing control material for rare genetic disorders and so on. The aim of this study was to determine optimized condition for reliable and reproducible LCLs from different sources. Medknow Publications & Media Pvt Ltd 2017-07-14 /pmc/articles/PMC5539668/ /pubmed/28808646 http://dx.doi.org/10.4103/2277-9175.210659 Text en Copyright: © 2017 Advanced Biomedical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Tousizadeh, Behnaz Moghim, Sharareh Chaleshtori, Ahmad Reza Salehi Ghanbarian, Maryam Mirian, Mina Salehi, Mansoor Tousizadeh, Sepideh Zaboli, Fatemeh Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
title | Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
title_full | Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
title_fullStr | Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
title_full_unstemmed | Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
title_short | Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies |
title_sort | application of epstein–barr virus for optimization of immortalized b-lymphocyte production as a positive control in genetic studies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539668/ https://www.ncbi.nlm.nih.gov/pubmed/28808646 http://dx.doi.org/10.4103/2277-9175.210659 |
work_keys_str_mv | AT tousizadehbehnaz applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT moghimsharareh applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT chaleshtoriahmadrezasalehi applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT ghanbarianmaryam applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT mirianmina applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT salehimansoor applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT tousizadehsepideh applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies AT zabolifatemeh applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies |